Investor Presentaiton

* Pricing Methodology: * FDA Priority or Breakthrough: Yes Ⓒ No Acquisition Cost: 0.00 New drug reporting: Data elements Trade Secret? Required if the drug was acquired Trade Secret? Acquisition Date: Required if the drug was acquired Trade Secret? Estimated Avg. Number of 0 Patients per Month: Patients per Month Description: 12

View entire presentation